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Antegrade refrac tory periods were obtained with the exfrastimulus meth od. The significant results were as follows: the sinus rate was 71 Â±4 beats per minute before, and 65 Â±3 beats per minute after methyldopa (P < 0.01). The mean A-H interval at a paced rate of 120 beats per minute was 113 Â± 14 msec before, and 135 Â±18 msec after, methyldopa (P M ethyldopa has been reported to produce severe symptomatic bradycardia in hypertensive pa tients.1 Carotid sinus hypersensitivity has also been documented after methyldopa administration. 2 We recently admitted a 63-year-old man to the coronarycareunitatMethodistHospital becauseof a 2:1 atrioventricular (AV) block. A His bundle ECG revealed a proximal block. The patient was taking only methyldopa for hypertension control. With cessation of the drug, normal conduction re turned in 48 hours. A repeat His bundle ECG, with right atrial pacing, was now normal.
Based on this experience, the present study involv ing 11 human subjects was undertaken to determine what effects intravenously administered methyldopa has on the cardiac conduction system.
MATERIALS @n METHODS
The study group consisted of 11 patients with organic heart disease. The clinical features of the group are sum marized in Table 1 . All patients were informed of the nature of the study, and informed consent was obtained. They were studied in the supine position in a postabsorptive nonsedated state.
Electrode catheters were percutaneously introduced and fluoroscopically positioned in the region of (1) the lateral wall of the right atrium near its junction with the superior vena cava to record from and stimulate the region of the high right atrium, and (2) 
DEFINITION OF ANTEGEADE CONDUCTION TERMs
The P-A Intervalâ€"The interval from the onset of the P wave during normal sinus conduction re corded on the standard ECG lead to the first rapid deflection of the A wave on the bipolar ECG. The P A time represents intratrial conduction time. The normal value is 27Â±18 msec.4 During atrial pacing, the P-A time is measured from the pacing impulse to A.
A-H Intervalâ€"The interval from the first rapid deflection of the A wave to the first rapid deflection of the bundle of His ECG. The A-H time represents conduction time through the A-V node. The normal value is 92 Â±38msec.4
H-V Intervalâ€"The interval from the first rapid bundle of His deflection to the onset of the QRS deflection in the ECG. The H-V interval approxi mates conduction time in the specialized tissues of the His-Purkinje system. The normal value is 43Â±12 msec.4 For each of these intervals, 10 beats were averaged before and after the administration of methyldopa, and the mean values were used for comparison.
In addition, the sinus node recovery time was obtained which is the interval from the last paced beat to the first spontaneous sinus beat after 1 or 2 minutes of atrial pacing at 120 or 130 per minute. The corrected sinus node recovery time was derived by deducting the prepacing sinus cycle length from the sinus node recovery time.
The following definitions were used in regard to antegrade refractory periods: A1, H1, and Vi are the atrial, His bundle, and ventricular ECGs of driven beats (Si); A2, H2, and V2 are the atrial, His bundle, and ventricular ECGs in response to the extrastimulus (S2). The atrial effective refractory period was the longest Si-S2 interval at which S2 did not result in atrial depolarization.
The AV nodal effective refractory period was the longest A1-A2 interval at which A2 failed to conduct to the bundle of His. The AV nodal functional refractory period was the shortest interval between H1-H2 both of which were propagated from the atrium. Methyldopa, 100 mg, was then administered in travenously over a 30-minute period to the 11 pa tients. After the termination of the infusion, the electrophysiologic studies were repeated. The blood pressure was alsoobtained, with a sphygmomanom eter, before and after the administration of methyl dopa. Statistical analysis of all data was performed using the Student t-test for paired data.
RESULTS
The effects of methyldopa administration on the cardiac conduction system are presented in Tables 2  and 3 .
Intra-Atrial Conduction
The P-A interval was measured in all patients. The mean P-A interval Â± SE was 23Â±1 before, and 25Â±2 msec after, methyldopa administration (NS). The atrial effective refractory period could be mea sured in all patients. The mean effective refractory 
ValueNS<0.01<0.001 Table 3â€"Effectsof Methyldopa on Refractory

Periods of the AV Conducting System5
tient by the administration of methyldopa.
Automaticity and Recovery Periods of the Sinus Node
The sinus rate was 71Â±4 msec before, and 65Â±3 msec after, methyldopa (P < 0.01). The sinus node recovery time significantly increased after methyl dopa administration.
The mean recovery time before and after methyldopa was 989 Â±55 msec and 1102Â± 66 msec, respectively (P < 0.05). However, the corrected sinus node recovery showed no significant change. This is primarily due to the slower sinus rate observed after methyldopa administration.
Blood Pressure
The mean values were respectively 142Â±7/86Â±2 mm Hg before, and 139Â±7/87Â±2 mm Hg after methyldopa (NS).
DISCUSSION
The present study revealed that methyldopa ad ministration produced a significant increase in the A-H interval at the various atrial pacing rates. In keeping with these findings is the fact that the func tional refractory period of the AV node significantly increased in all patients. Further, the effective re fractory period of the AV node also lengthened in the six patients in whom this interval could be mea sured. Methyldopa did not affect His Purkinje con duction time (H-V interval) during sinus rhythm or over a wide range of paced atrial rates. The P-A interval, a measure of conduction from the high to low atrium, was unaltered after the administration of methyldopa. The sinus node recovery time signifi cantly increased in every patient after methyldopa, while the sinus rate fell in every patient after the drug administration.
Scheinman and his co-workers' reported that symptomatic sinus bradycardia can be produced in patients receiving methyldopa. An inhibition in cen tral sympathetic tone resulting in overt sinus node dysfunction has been postulated as a possible mechanism. Alternatively, the sinus slowing may be related to direct depressant effects of this drug on sinus node function.
Tuganowski and Wolanski5 studied 15 isolated preparations of the sinus node of rabbit hearts and recorded bioelectric activity with glass microelectrodes. It was found that methyldopa administration arrested the spontaneous activity of the isolated sinus node pacemaker. These workers did not study the effect of methyldopa on the AV node, but presumably, the same depressant action would have been demonstrated. 5ERP indicates effective refractory period; FRP, functional refractory period; and elipses, electrophysiologic studies limited due to atrial refractoriness. periods of the atrium was 262Â±15 msec before, and 278Â± 19 msec after, methyldopa administration (NS).
AV Nodal Conduction
The A-H intervals could be measured in all pa tients. The mean A-H interval during sinus rhythm was 83Â±9 msec before, and 87Â±9 msec after, methyldopa (NS). With atrial pacing, A-H intervals at equivalent paced rates (100 to 140 per minute) were significantly different before and after methyl dopa. For example, the mean A-H interval at a paced rate of 120 per minute in ten patients was 113Â±14 msec before, and 135Â±18 msec after, methyldopa (P <0.05).
The paced rate at which Wenckebach periods proximal to the His bundle occurred was noted in seven patients. The mean rate was 141Â±6 beats per minute before, and 137Â±6 beats per minute after, methyldopa (NS). The mean AV nodal functional refractory period was 430Â±23 msec before, and 452Â±24 msec after, methyldopa (P < 0.001). The effective refractory period of the AV node was 358Â± 29 msec before, and 388Â±27 msec after, adininistra tion of methyldopa (P < 0.01).
Intraventricular Conduction
The H-V intervals were not changed in any pa
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The results in our present study are probably due to reduced sympathetic tone and consequent relative preponderance of parasympathetic effects. From the clinical standpoint, methyldopa can probably act with other drugs which depress AV nodal conduction and produce second-degree heart block. Digitalis and propranolol hydrochloride (In deral) are the commonly used agents which have these AV nodal depressing actions. However, methyldopa can produce second-degree heart block without the addition of other drugs. Similarly, methyldopa can produce marked sinus slowing or can interact with other drugs that depress the auto maticity of the sinus node.
